20Nov/13

Supplement linked to liver failure, hepatitis recalled – Big News Network.com

Organ Failure

Daily Mail

Supplement linked to liver failure, hepatitis recalled
Big News Network.com
“As soon as we suspected a possible link between OxyElite Pro products and cases of liver failure and non-viral hepatitis in Hawaii, we warned the public and immediately began an investigation with state officials and the Centers for Disease Control …
Diet Supplement Recalled After Being Linked to Liver Failure and DeathFood Consumer
OxyElite Pro Supplements RecalledFDA.gov
Hepatitis Outbreak Traced to OxyElite Diet SupplementsCourthouse News Service
Daily Mail –Food Safety News
all 86 news articles »
19Nov/13

Mesoblast limited : MPCs Strengthen Cardiac Function in End-Stage Heart Failure – 4-traders (press release)

Organ Failure

Science Codex

Mesoblast limited : MPCs Strengthen Cardiac Function in End-Stage Heart Failure
4-traders (press release)
The researchers reported that a single injection into the native heart of 25 million allogeneic, or “off-the-shelf”, MPCs resulted in an improvement in cardiac function at the pre-specified key efficacy endpoint of 90 days, as measured by the ability …
Heart failure patients receiving LVAD may benefit from injection of powerful …News-Medical.net
Mesoblast MPCs improve function in heart failureAustralian Life Scientist
Mesoblast’s Cell Therapy Strengthens Native Heart Function In Patients With …MarketWatch
irasia.com (press release)
all 19 news articles »
19Nov/13

End-Stage Heart Failure Patients Benefit from Injection of Millions of … – Science Daily (press release)

Organ Failure

Science Codex

End-Stage Heart Failure Patients Benefit from Injection of Millions of …
Science Daily (press release)
18, 2013 — A multicenter team of researchers within the NIH-funded Cardiothoracic Surgical Trials Network (CTSN), led by Icahn School of Medicine at Mount Sinai, have found end-stage heart failure patients who receive a surgically implanted left …
Mesoblast limited : MPCs Strengthen Cardiac Function in End-Stage Heart Failure4-traders (press release)
Mesoblast’s Cell Therapy Strengthens Native Heart Function In Patients With …GlobeNewswire (press release)

all 19 news articles »
19Nov/13

TOPCAT: Spironolactone cuts hospitalizations for diastolic heart failure – Family Practice News Digital Network

Organ Failure

TOPCAT: Spironolactone cuts hospitalizations for diastolic heart failure
Family Practice News Digital Network
DALLAS – Spironolactone did not hit a home run in the large international “treatment of preserved cardiac function heart failure with an aldosterone antagonist” (TOPCAT) trial, but it did knock out a solid single in the form of significantly reduced …
19Nov/13

Long-Lasting Gene Therapy Benefits Advanced Heart Failure Patients – Science Daily (press release)

Organ Failure

Long-Lasting Gene Therapy Benefits Advanced Heart Failure Patients
Science Daily (press release)
19, 2013 — Researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai reported the long-term benefits of a single dose of their gene therapy AAV1/SERCA2a in advanced heart failure patients on Nov. 19 at the …

and more »